Status:
COMPLETED
Safety and Efficacy of Ohhmed Treatments for the Improvement of Erectile Dysfunction - A Feasibility Study
Lead Sponsor:
OHH-MED Medical Ltd
Conditions:
Erectile Dysfunction
Eligibility:
MALE
40-85 years
Phase:
NA
Brief Summary
Erectile dysfunction, the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance, is estimated to affect up to 30 million men in the United States. The ...
Eligibility Criteria
Inclusion
- IIEF-EF score of 11-24 with or without the use of medication (PDE5 inhibitors).
- Erectile dysfunction for at least 3- months
- Steady relationship for at least 3-months.
- patient without sensory disorders
- patient with established organic of erectile dysfunction
Exclusion
- investigator's impression of expected poor patient compliance or anatomic inadequacy (penile size/girth)
- Premature ejaculation
- Any psychiatric disorder
- Epilepsy
- Peyronie 's disease/ penile curvature
- Coagulopathy
- Any tumor in the pelvic or penile region within the last 3 years
Key Trial Info
Start Date :
January 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2021
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04484090
Start Date
January 20 2019
End Date
September 20 2021
Last Update
January 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Medical center
Haifa, Israel, 3525408